An ontology for drug-drug interactions

Proceedings of: The 6th International Workshop on Semantic Web Applications and Tools for Life Sciences (SWAT4LS 2013). Took place 2013, December 11-12, in Edinburgh, UK. The evnt Web site http://www.swat4ls.org/workshops/edinburgh2013/Drug-drug interactions form a significant risk group for adverse effects associ-ated with pharmaceutical treatment. These interactions are often reported in the literature, however, they are sparsely represented in machine-readable re-sources, such as online databases, thesauri or ontologies. These knowledge sources play a pivotal role in Natural Language Processing (NLP) systems since they provide a knowledge representation about the world or a particular do-main. While ontologies for drugs and their effects have proliferated in recent years, there is no ontology capable of describing and categorizing drug-drug in-teractions. Moreover, there is no artifact that represents all the possible mecha-nisms that can lead to a DDI. To fill this gap we propose DINTO, an ontology for drug-drug interactions and their mechanisms. In this paper we describe the classes, relationships and overall structure of DINTO. The ontology is free for use and available at https://code.google.com/p/dinto/This work was supported by the Regional Government of Madrid under the Research Network MA2VICMR [S2009/TIC-1542], by the Spanish Ministry of Education under the project MULTIMEDICA [TIN2010-20644-C03-01] and by the European Commission Seventh Framework Programme under the project TrendMiner_Enlarged (EU FP7-ICT 612336).Publicad

Semantic resources in pharmacovigilance: a corpus and an ontology for drug-drug interactions

Mención Internacional en el título de doctorNowadays, with the increasing use of several drugs for the treatment of one or more different diseases (polytherapy) in large populations, the risk for drugs combinations that have not been studied in pre-authorization clinical trials has increased. This provides a favourable setting for the occurrence of drug-drug interactions (DDIs), a common adverse drug reaction (ADR) representing an important risk to patients safety, and an increase in healthcare costs. Their early detection is, therefore, a main concern in the clinical setting. Although there are different databases supporting healthcare professionals in the detection of DDIs, the quality of these databases is very uneven, and the consistency of their content is limited. Furthermore, these databases do not scale well to the large and growing number of pharmacovigilance literature in recent years. In addition, large amounts of current and valuable information are hidden in published articles, scientific journals, books, and technical reports. Thus, the large number of DDI information sources has overwhelmed most healthcare professionals because it is not possible to remain up to date on everything published about DDIs. Computational methods can play a key role in the identification, explanation, and prediction of DDIs on a large scale, since they can be used to collect, analyze and manipulate large amounts of biological and pharmacological data. Natural language processing (NLP) techniques can be used to retrieve and extract DDI information from pharmacological texts, supporting researchers and healthcare professionals on the challenging task of searching DDI information among different and heterogeneous sources. However, these methods rely on the availability of specific resources providing the domain knowledge, such as databases, terminological vocabularies, corpora, ontologies, and so forth, which are necessary to address the Information Extraction (IE) tasks. In this thesis, we have developed two semantic resources for the DDI domain that make an important contribution to the research and development of IE systems for DDIs. We have reviewed and analyzed the existing corpora and ontologies relevant to this domain, based on their strengths and weaknesses, we have developed the DDI corpus and the ontology for drug-drug interactions (named DINTO). The DDI corpus has proven to fulfil the characteristics of a high-quality gold-standard, and has demonstrated its usefulness as a benchmark for the training and testing of different IE systems in the SemEval-2013 DDIExtraction shared task. Meanwhile, DINTO has been used and evaluated in two different applications. Firstly, it has been proven that the knowledge represented in the ontology can be used to infer DDIs and their different mechanisms. Secondly, we have provided a proof-of-concept of the contribution of DINTO to NLP, by providing the domain knowledge to be exploited by an IE pilot prototype. From these results, we believe that these two semantic resources will encourage further research into the application of computational methods to the early detection of DDIs. This work has been partially supported by the Regional Government of Madrid under the Research Network MA2VICMR [S2009/TIC-1542], by the Spanish Ministry of Education under the project MULTIMEDICA [TIN2010-20644-C03-01] and by the European Commission Seventh Framework Programme under TrendMiner project [FP7-ICT287863].Hoy en día ha habido un notable aumento del número de pacientes polimedicados que reciben simultáneamente varios fármacos para el tratamiento de una o varias enfermedades. Esta situación proporciona el escenario ideal para la prescripción de combinaciones de fármacos que no han sido estudiadas previamente en ensayos clínicos, y puede dar lugar a un aumento de interacciones farmacológicas (DDIs por sus siglas en inglés). Las interacciones entre fármacos son un tipo de reacción adversa que supone no sólo un riesgo para los pacientes, sino también una importante causa de aumento del gasto sanitario. Por lo tanto, su detección temprana es crucial en la práctica clínica. En la actualidad existen diversos recursos y bases de datos que pueden ayudar a los profesionales sanitarios en la detección de posibles interacciones farmacológicas. Sin embargo, la calidad de su información varía considerablemente de unos a otros, y la consistencia de sus contenidos es limitada. Además, la actualización de estos recursos es difícil debido al aumento que ha experimentado la literatura farmacológica en los últimos años. De hecho, mucha información sobre DDIs se encuentra dispersa en artículos, revistas científicas, libros o informes técnicos, lo que ha hecho que la mayoría de los profesionales sanitarios se hayan visto abrumados al intentar mantenerse actualizados en el dominio de las interacciones farmacológicas. La ingeniería informática puede representar un papel fundamental en este campo permitiendo la identificación, explicación y predicción de DDIs, ya que puede ayudar a recopilar, analizar y manipular grandes cantidades de datos biológicos y farmacológicos. En concreto, las técnicas del procesamiento del lenguaje natural (PLN) pueden ayudar a recuperar y extraer información sobre DDIs de textos farmacológicos, ayudando a los investigadores y profesionales sanitarios en la complicada tarea de buscar esta información en diversas fuentes. Sin embargo, el desarrollo de estos métodos depende de la disponibilidad de recursos específicos que proporcionen el conocimiento del dominio, como bases de datos, vocabularios terminológicos, corpora u ontologías, entre otros, que son necesarios para desarrollar las tareas de extracción de información (EI). En el marco de esta tesis hemos desarrollado dos recursos semánticos en el dominio de las interacciones farmacológicas que suponen una importante contribución a la investigación y al desarrollo de sistemas de EI sobre DDIs. En primer lugar hemos revisado y analizado los corpora y ontologías existentes relevantes para el dominio y, en base a sus potenciales y limitaciones, hemos desarrollado el corpus DDI y la ontología para interacciones farmacológicas DINTO. El corpus DDI ha demostrado cumplir con las características de un estándar de oro de gran calidad, así como su utilidad para el entrenamiento y evaluación de distintos sistemas en la tarea de extracción de información SemEval-2013 DDIExtraction Task. Por su parte, DINTO ha sido utilizada y evaluada en dos aplicaciones diferentes. En primer lugar, hemos demostrado que esta ontología puede ser utilizada para inferir interacciones entre fármacos y los mecanismos por los que ocurren. En segundo lugar, hemos obtenido una primera prueba de concepto de la contribución de DINTO al área del PLN al proporcionar el conocimiento del dominio necesario para ser explotado por un prototipo de un sistema de EI. En vista de estos resultados, creemos que estos dos recursos semánticos pueden estimular la investigación en el desarrollo de métodos computaciones para la detección temprana de DDIs. Este trabajo ha sido financiado parcialmente por el Gobierno Regional de Madrid a través de la red de investigación MA2VICMR [S2009/TIC-1542], por el Ministerio de Educación Español, a través del proyecto MULTIMEDICA [TIN2010-20644-C03-01], y por el Séptimo Programa Macro de la Comisión Europea a través del proyecto TrendMiner [FP7-ICT287863].This work has been partially supported by the Regional Government of Madrid under the Research Network MA2VICMR [S2009/TIC-1542], by the Spanish Ministry of Education under the project MULTIMEDICA [TIN2010-20644-C03-01] and by the European Commission Seventh Framework Programme under TrendMiner project [FP7-ICT287863].Programa Oficial de Doctorado en Ciencia y Tecnología InformáticaPresidente: Asunción Gómez Pérez.- Secretario: María Belén Ruiz Mezcua.- Vocal: Mariana Neve

Medical data processing and analysis for remote health and activities monitoring

Recent developments in sensor technology, wearable computing, Internet of Things (IoT), and wireless communication have given rise to research in ubiquitous healthcare and remote monitoring of human\u2019s health and activities. Health monitoring systems involve processing and analysis of data retrieved from smartphones, smart watches, smart bracelets, as well as various sensors and wearable devices. Such systems enable continuous monitoring of patients psychological and health conditions by sensing and transmitting measurements such as heart rate, electrocardiogram, body temperature, respiratory rate, chest sounds, or blood pressure. Pervasive healthcare, as a relevant application domain in this context, aims at revolutionizing the delivery of medical services through a medical assistive environment and facilitates the independent living of patients. In this chapter, we discuss (1) data collection, fusion, ownership and privacy issues; (2) models, technologies and solutions for medical data processing and analysis; (3) big medical data analytics for remote health monitoring; (4) research challenges and opportunities in medical data analytics; (5) examples of case studies and practical solutions

High-Performance Modelling and Simulation for Big Data Applications

This open access book was prepared as a Final Publication of the COST Action IC1406 “High-Performance Modelling and Simulation for Big Data Applications (cHiPSet)“ project. Long considered important pillars of the scientific method, Modelling and Simulation have evolved from traditional discrete numerical methods to complex data-intensive continuous analytical optimisations. Resolution, scale, and accuracy have become essential to predict and analyse natural and complex systems in science and engineering. When their level of abstraction raises to have a better discernment of the domain at hand, their representation gets increasingly demanding for computational and data resources. On the other hand, High Performance Computing typically entails the effective use of parallel and distributed processing units coupled with efficient storage, communication and visualisation systems to underpin complex data-intensive applications in distinct scientific and technical domains. It is then arguably required to have a seamless interaction of High Performance Computing with Modelling and Simulation in order to store, compute, analyse, and visualise large data sets in science and engineering. Funded by the European Commission, cHiPSet has provided a dynamic trans-European forum for their members and distinguished guests to openly discuss novel perspectives and topics of interests for these two communities. This cHiPSet compendium presents a set of selected case studies related to healthcare, biological data, computational advertising, multimedia, finance, bioinformatics, and telecommunications

Metodología para el diseño de redes de ontologías en el área medica

"Este trabajo de tesis contiene la descripción de una metodología de diseño de redes de ontologías a partir del uso de recursos ontológicos y no ontológicos. Esta metodología tiene la finalidad de brindar elementos necesarios para el diseño de nuevas ontologías, reutilización de ontologías existentes, enriquecimiento de la red por medio de la integración de recursos no ontológicos y evaluación de la red resultante, impactando así a diversas áreas de la ingeniera ontológica ya que propone enriquecimiento de una red de ontologías sin modificar la estructura de las ontologías participantes. Esto último permite que esta metodología resalte sobre las existentes en la literatura. Este trabajo también ofrece una aplicación de la metodología de diseño de redes, la cual se enfoca en la construcción de una red de ontologías acerca de la diabetes mellitus (RODM) enfocada a la representación de información respecto a la población mexicana, con la finalidad de brindar apoyo en la toma de decisiones médicas. Esta red considera la representación de factores de riesgo, síntomas, signos, diagnostico, enfermedades y tratamiento relacionados a la diabetes mellitus (DM); así como información´ de historiales médicos de personas que ya padecen dicha enfermedad y sus complicaciones"

High-Performance Modelling and Simulation for Big Data Applications

This open access book was prepared as a Final Publication of the COST Action IC1406 “High-Performance Modelling and Simulation for Big Data Applications (cHiPSet)“ project. Long considered important pillars of the scientific method, Modelling and Simulation have evolved from traditional discrete numerical methods to complex data-intensive continuous analytical optimisations. Resolution, scale, and accuracy have become essential to predict and analyse natural and complex systems in science and engineering. When their level of abstraction raises to have a better discernment of the domain at hand, their representation gets increasingly demanding for computational and data resources. On the other hand, High Performance Computing typically entails the effective use of parallel and distributed processing units coupled with efficient storage, communication and visualisation systems to underpin complex data-intensive applications in distinct scientific and technical domains. It is then arguably required to have a seamless interaction of High Performance Computing with Modelling and Simulation in order to store, compute, analyse, and visualise large data sets in science and engineering. Funded by the European Commission, cHiPSet has provided a dynamic trans-European forum for their members and distinguished guests to openly discuss novel perspectives and topics of interests for these two communities. This cHiPSet compendium presents a set of selected case studies related to healthcare, biological data, computational advertising, multimedia, finance, bioinformatics, and telecommunications

Drug repositioning and indication discovery using description logics

Drug repositioning is the discovery of new indications for approved or failed drugs. This practice is commonly done within the drug discovery process in order to adjust or expand the application line of an active molecule. Nowadays, an increasing number of computational methodologies aim at predicting repositioning opportunities in an automated fashion. Some approaches rely on the direct physical interaction between molecules and protein targets (docking) and some methods consider more abstract descriptors, such as a gene expression signature, in order to characterise the potential pharmacological action of a drug (Chapter 1). On a fundamental level, repositioning opportunities exist because drugs perturb multiple biological entities, (on and off-targets) themselves involved in multiple biological processes. Therefore, a drug can play multiple roles or exhibit various mode of actions responsible for its pharmacology. The work done for my thesis aims at characterising these various modes and mechanisms of action for approved drugs, using a mathematical framework called description logics. In this regard, I first specify how living organisms can be compared to complex black box machines and how this analogy can help to capture biomedical knowledge using description logics (Chapter 2). Secondly, the theory is implemented in the Functional Therapeutic Chemical Classification System (FTC - https://www.ebi.ac.uk/chembl/ftc/), a resource defining over 20,000 new categories representing the modes and mechanisms of action of approved drugs. The FTC also indexes over 1,000 approved drugs, which have been classified into the mode of action categories using automated reasoning. The FTC is evaluated against a gold standard, the Anatomical Therapeutic Chemical Classification System (ATC), in order to characterise its quality and content (Chapter 3). Finally, from the information available in the FTC, a series of drug repositioning hypotheses were generated and made publicly available via a web application (https://www.ebi.ac.uk/chembl/research/ftc-hypotheses). A subset of the hypotheses related to the cardiovascular hypertension as well as for Alzheimer’s disease are further discussed in more details, as an example of an application (Chapter 4). The work performed illustrates how new valuable biomedical knowledge can be automatically generated by integrating and leveraging the content of publicly available resources using description logics and automated reasoning. The newly created classification (FTC) is a first attempt to formally and systematically characterise the function or role of approved drugs using the concept of mode of action. The open hypotheses derived from the resource are available to the community to analyse and design further experiments.This work was supported by the European Molecular Biology Laboratory (EMBL)